COVID-19 patients who are vaccinated -- and were hospitalized with reduced kidney function -- had better outcomes than unvaccinated patients, a new study finds.

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if backed by outcomes, herald a “new age” of care, suggests a ...

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave off the disease’s worst effects.

Key takeaways: Patients with CKD who received an education handout before a nephrology visit had a 19 percentage point increase in knowledge post-visit.

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes organization, updated recommendations are presented for the evaluation, management, and treatment of ...

Akebia plans to kick off a phase 3 trial to assess Vafseo as a potential treatment for anemia in late-stage CKD patients who aren’t on dialysis.

Review information on how to manage the costs of kidney disease treatments like dialysis, medication, and transplantation, and resources for support.

The Kidney Disease: Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney disease (CKD) management.

Furoscix is expected to be available for CKD patients in April 2025. The Food and Drug Administration (FDA) has expanded the approval of Furoscix ® (furosemide injection) to include the treatment ...

Life coach Jennifer Gowans shares how helping others became her go-to coping strategy for living with chronic kidney disease and type 2 diabetes.

CKD, affecting 9.1% of the global population, is linked to an increased risk for cardiovascular disease (CVD), kidney failure, and death. While advances in medical therapy for CKD, particularly in ...

The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition.Results ...